49
Participants
Start Date
April 20, 2018
Primary Completion Date
August 23, 2023
Study Completion Date
August 23, 2023
"StellarexTM 0.014 Over-The-Wire Drug-coated Angioplasty Balloon"
"The Stellarex balloon (0.014) is indicated for the treatment of de-novo or re-stenotic lesions in the lower extremities to establish blood flow and to maintain vessel patency."
Cardiologisches Centrum Bethanien, Frankfurt
Asklepios Kliniken Hamburg GmbH, Hamburg
Klinik Immenstadt, Herz und GefaSzentrum Immenstadt, Immenstadt im Allgäu
Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz
RoMed Klinikum Rosenheim, Rosenheim
Albert Schweitzer Hospital, Dordrecht
St. Antonius Hospital, Nieuwegein
Cambridge University Hospital, Cambridge
Guys and St. Thomas Hospital, London
The Royal Free Hospital, London
Spectranetics Corporation
INDUSTRY